Elmar Schärli

Director of Finance/CFO at

Xigen SA

54 year

Health Technology

Profile

Elmar Schärli is currently the Director at Zilentin AG and the Chief Financial Officer at Xigen SA. Previously, he worked as the Chief Financial Officer at Altamira Therapeutics Ltd. from 2019 to 2021.

Elmar Schärli active positions

Companies	Position	Start
Xigen SA Xigen SA Pharmaceuticals: MajorHealth Technology Develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer	Director of Finance/CFO	-
Zilentin AG Zilentin AG BiotechnologyHealth Technology Develops and supplies peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues	Director/Board Member	-

All active positions of Elmar Schärli

Former positions of Elmar Schärli

Companies	Position	End
ALTAMIRA THERAPEUTICS LTD.	Director of Finance/CFO	2021-10-31

See the detail of Elmar Schärli's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elmar Schärli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Xigen SA Xigen SA Pharmaceuticals: MajorHealth Technology Develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer	Health Technology
Altamira Therapeutics Ltd. Altamira Therapeutics Ltd. BiotechnologyHealth Technology Develops RNA therapeutics for inner ear disorders	Health Technology
Zilentin AG Zilentin AG BiotechnologyHealth Technology Develops and supplies peptide-based nanoparticles for efficient RNA delivery to extrahepatic tissues	Health Technology